KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,324,000 | +73.4% | 12,922 | 0.0% | 1.04% | +70.2% |
| Q2 2017 | $1,340,000 | -4.5% | 12,922 | -27.7% | 0.61% | +9.1% |
| Q1 2017 | $1,403,000 | +351.1% | 17,872 | +253.7% | 0.56% | +275.2% |
| Q4 2015 | $311,000 | +10.7% | 5,053 | 0.0% | 0.15% | +4.2% |
| Q3 2015 | $281,000 | -8.8% | 5,053 | 0.0% | 0.14% | +2.1% |
| Q2 2015 | $308,000 | +5.8% | 5,053 | 0.0% | 0.14% | +5.3% |
| Q1 2015 | $291,000 | – | 5,053 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |